Company / Net Debt per Share
Sonoma Pharmaceuticals, Inc. Net Debt per Share History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$3.53
FY2022
5-year range
-$3.53 / -$3.53
FY2018-FY2022
Trend
-163.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.80 to $-3.53 over the past 2 years.
Based on SEC 10-K filings.
-3.53 in FY2022.
Improved from $-2.80 to $-3.53 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, net debt per share decreased 163.8% year-over-year.
- Peak net debt per share was recorded in FY2021.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$3.53 | -163.8% |
| FY2021 | -$1.34 | +52.2% |
| FY2020 | -$2.80 | +80.9% |
| FY2019 | -$14.66 | -260.8% |
| FY2018 | -$4.06 | -129.7% |
| FY2017 | -$1.77 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026